Evaluating the risk: Hepatitis B virus reactivation in ocrelizumab-treated patients with multiple sclerosis: A single-center experience and review of the literature [0.03%]
奥克雷珠单抗治疗多发性硬化患者的乙型肝炎病毒再激活:一家医院的经验和文献回顾
Bahadır Orkun Ozbay,Uğur Kulu,Aliye Baştuğ et al.
Bahadır Orkun Ozbay et al.
Background: Ocrelizumab is a highly effective anti-CD20 monoclonal antibody used in the treatment of multiple sclerosis (MS). However, B-cell depletion may increase the risk of hepatitis B virus (HBV) reactivation, partic...
Effectiveness of the adapted Unified Protocol (UP-MSo) in relapsing-remitting multiple sclerosis with overweight/obesity: A pre-registered randomized controlled trial on emotion regulation, eating behavior, and neurological outcomes [0.03%]
适应性统一协议(UP-MSo)在复发缓解型多发性硬化症伴肥胖或超重患者中的有效性:一项关于情绪调节、饮食行为和神经结果的预注册随机对照试验
Maria Consuelo San Martín,Marcos Domic-Siede,Marcela Soto et al.
Maria Consuelo San Martín et al.
Background: Relapsing-remitting multiple sclerosis (RRMS) is frequently associated with anxiety, depression, and emotion regulation difficulties, which may foster maladaptive coping strategies such as emotional eating and...
Evaluation of the predictive value of C-reactive protein-albumin-lymphocyte (CALLY) index for disability and severity in multiple sclerosis [0.03%]
评估C反应蛋白-白蛋白-淋巴细胞(CALLY)指数对多发性硬化症残疾和严重程度预测价值的效果
Yesim Eylev Akboga
Yesim Eylev Akboga
Background: Multiple sclerosis (MS) is a demyelinating disease in which chronic inflammation is predominant in nerve tissue, characterized by neurodegeneration and variable neurological impairment, as well as immune syste...
Serum angiogenesis-hypoxia biomarkers in relapsing-remitting multiple sclerosis [0.03%]
复发缓解型多发性硬化症患者血清中血管生成-低氧生物标志物的研究
Heather Y F Yong,Nicholas J Batty,Serena Phillips et al.
Heather Y F Yong et al.
Background: Studies have demonstrated that the hypoxia-angiogenic axis is dysregulated in progressive multiple sclerosis (MS), with an upregulation of hypoxic biomarkers with a paradoxical reduction of angiogenic biomarke...
Sex differences in healthcare use before the first multiple sclerosis-related demyelinating event [0.03%]
多发性硬化症相关脱髓鞘事件之前的医疗服务利用性别差异
Farahnaz Amini,Karl Everett,Feng Zhu et al.
Farahnaz Amini et al.
While the multiple sclerosis (MS) prodrome may be prolonged, healthcare use by sex >5 years pre-onset remains underexplored. We examined healthcare use up to 29 years pre-MS onset, stratified by sex. Using administrative data from Ontario, ...
Multiple sclerosis during an emergency or crisis: A narrative review focused on the effect of war and COVID-19 pandemic [0.03%]
急危情况下多发性硬化症的发病状况:聚焦战争与新冠疫情下的叙事性综述研究
Masoud Etemadifar,Mehri Salari,Kamran Rezaei et al.
Masoud Etemadifar et al.
Background: Armed conflict fractures the systems that multiple sclerosis (MS) care depends on, yet MS-specific guidance for war is scarce. The aim of this study is to synthesize evidence on MS care during armed conflict a...
Quantitative MRI metrics associated with lesion evolution in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) [0.03%]
与髓磷脂少突胶质细胞糖蛋白抗体相关疾病(MOGAD)病灶演变相关的定量磁共振成像指标
Jiali Sun,Siyao Xu,Huabing Wang et al.
Jiali Sun et al.
Objectives: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is characterized by demyelinating lesions that often resolve on follow-up, but imaging factors associated with lesion resolution remain u...
The EBV timing hypothesis: How the age of primary infection may explain global variation in multiple sclerosis [0.03%]
EB病毒定时假说——为何初感染的年龄可能解释了多发性硬化在全球的差异分布
Laura R Naydovich,Joseph R Berger
Laura R Naydovich
The age of acquisition of EBV infection has been suggested to be determinative in whether an individual develops multiple sclerosis. This correlation may be the consequence of the difference in the immune response to EBV between children an...
Corrigendum to "A systematic review of the clinical utility of retinal optical coherence tomography in childhood acquired demyelinating syndromes" [Multiple Sclerosis and Related Disorders 111 (2026) 107206] [0.03%]
关于“儿童获得性脱髓鞘综合征临床应用的系统回顾——视网膜光学相干断层扫描”[多发性硬化及相关障碍,卷111(2026),页107206]的勘误表
Michiel S J Buijze,C Louk de Mol,Sjoukje E Loudon et al.
Michiel S J Buijze et al.
Gavin Giovannoni,Jeannette Lechner-Scott,Michael Levy et al.
Gavin Giovannoni et al.